BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25170273)

  • 1. The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer.
    Chen Y; Sun J; Zhao H; Zhu D; Zhi Q; Song S; Zhang L; He S; Kuang Y; Zhang Z; Li D
    Onco Targets Ther; 2014; 7():1465-72. PubMed ID: 25170273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.
    Wang L; Cao NN; Wang S; Man HW; Li PF; Shan BE
    Tumour Biol; 2016 Mar; 37(3):2961-71. PubMed ID: 26411671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
    Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
    Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Programmed Death Ligand-1 in Discriminating Patients With Lymph Node-Negative, p53-Wild-Type, or Low-BRCA1/2-Expression Pancreatic Ductal Adenocarcinoma.
    Chen X; Zhang Y; Mo S; Ma H; Lu Z; Yu S; Chen J
    Arch Pathol Lab Med; 2023 Apr; 147(4):465-473. PubMed ID: 35862858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.
    Geng Y; Wang H; Lu C; Li Q; Xu B; Jiang J; Wu C
    Int J Clin Oncol; 2015 Apr; 20(2):273-81. PubMed ID: 24804867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis.
    Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L
    Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of costimulatory molecule B7-H3 expression on CD3(+) T cells in colorectal carcinoma.
    Mao Y; Sun J; Wang WP; Zhang XG; Hua D
    Chin Med J (Engl); 2013 Aug; 126(16):3035-8. PubMed ID: 23981607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and Subcellular Distribution of Costimulatory Molecules B7-H1,B7-H3 and B7-H4 in Human Hematologic Malignancy Cell Lines].
    Zhang W; Wang J; Wang YF; Zhu MX; Wan WL; Li HS; Wu FF; Yan XX; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1539-1546. PubMed ID: 27784389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer.
    Si S; Wang L; Cao H; Xu Y; Zhan Q
    BMC Cancer; 2022 Feb; 22(1):211. PubMed ID: 35219310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer.
    Yang J; Tian Z; Gao H; Xiong F; Cao C; Yu J; Shi W; Zhan Q; Yang C
    BMC Cancer; 2022 May; 22(1):584. PubMed ID: 35624419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis.
    Guo L; Liu Z; Zhang Y; Quan Q; Huang L; Xu Y; Cao L; Zhang X
    Medicine (Baltimore); 2019 Feb; 98(8):e14663. PubMed ID: 30813210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
    Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
    Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
    [No Abstract]   [Full Text] [Related]  

  • 13. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
    Kim NI; Park MH; Kweon SS; Lee JS
    Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer.
    Xu H; Chen X; Tao M; Chen K; Chen C; Xu G; Li W; Yuan S; Mao Y
    Oncol Lett; 2016 Mar; 11(3):1841-1846. PubMed ID: 26998087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
    Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
    Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province.
    Liang M; Li J; Wang D; Li S; Sun Y; Sun T; Zhang J; Chen X; Li Q; Sun S
    Tumour Biol; 2014 Jan; 35(1):55-60. PubMed ID: 23873101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer.
    Loos M; Hedderich DM; Ottenhausen M; Giese NA; Laschinger M; Esposito I; Kleeff J; Friess H
    BMC Cancer; 2009 Dec; 9():463. PubMed ID: 20035626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
    Kim GE; Kim NI; Park MH; Lee JS
    Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
    Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
    Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
    Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
    Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.